Michael W. Jann, PharmD, FCCP, FCP, BCPP

Jann

Professor of Pharmacotherapy

 

Education & Experience:

I received a BS in Biology from the California State University in Los Angeles and a PharmD from the University of Southern California. I completed a postdoctoral residency in mental health pharmacy practice at the University of Tennessee in Memphis. I have held a full-time faculty position at Mercer University COPHS and was the Chair of the Department for Pharmacy Practice. I was a part-time faculty member at the University of Texas at Austin in the Division of Pharmacotherapy in San Antonio.

Teaching Areas & Interests:

I have been involved in both professional, postdoctoral residency and fellowship education in pharmacy for more than 25 years. My teaching efforts in the doctor of pharmacy program have focused mainly on central nervous system medications. I have taught in a variety of other courses such as Introduction to Pharmacy and Health Care Systems, Pharmacy Law, and in the Clinical Skills Laboratory. I have had the opportunity to supervise and mentor postdoctoral residents and fellows who have taken various positions in the pharmaceutical industry, pharmacy practice and the academy.

Professional Activities & Awards:

I am an active member of several professional organizations including the American Association of Colleges of Pharmacy, American College of Clinical Pharmacy, and the American College of Clinical Pharmacology. I served as the Treasurer for the American College of Clinical Pharmacology, a member of its Executive Committee, and on the Board of Regents.

Scholarly Interests:

My research has focused mainly in drug development and clinical research to treat psychiatric and geriatric patients. The mechanistic impact of drug-drug interactions (e.g. CYP enzymes, drug transporters, and etc…) and drug formulations applied to patient safety and efficacy is integrated with research in the clinical sciences. From a clinical pharmacy service perspective, my efforts concentrate on the role of pharmacists in medication therapy management (MTM) and collaborative practices with reimbursement in the ambulatory care environment. Finally, a recently completed AHRQ project on Academic Detailing by clinical pharmacists demonstrated that prescribers can be significantly influenced to utilized evidence-based medical protocols to improve patient treatment and outcomes.

Recent Publications:

Jann MW, Penzak SR, Cohen LJ, eds. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents, 1st Edition, Springer Press, Spring 2016.

Jann MW, Kennedy WK. Antipsychotics. In: Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Jann MW, Penzak SR, Cohen LJ, eds 1st Edition, Springer Press, Spring 2016, p. 139-176.

VanDenBerg CM, Jann MW. Antidementia Drugs. In: Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Jann MW, Penzak SR, Cohen LJ, eds 1st Edition, Springer Press, Spring 2016, p. 329-350.

Jann MW. Antiaddiction Drugs. In: Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Jann MW, Penzak SR, Cohen LJ, eds 1st Edition, Springer Press, Spring 2016, p. 351-372.

Jann MW. Anesthetics. In: Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Jann MW, Penzak SR, Cohen LJ, eds 1st Edition, Springer Press, Spring 2016, p. 373-394.

Jann MW. Drug Interactions with Anesthetic Drugs. In: Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Jann MW, Penzak SR, Cohen LJ, eds 1st Edition, Springer Press, Spring 2016, p. 579-601.

Jann MW and Penzak SR. Newer long-acting injectable formulations of atypical antipsychotics. CNS Drugs 2018; 32: 241-252.

Link to Dr. Jann’s University Profile

This page was last modified on October 4, 2018